Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?
Clark David A·Inflammopharmacology
Concern has been raised about an increased risk of lymphoma and skin cancers in patients with rheumatoid arthritis due to administration of anti-TNF-α drugs. Meta-analysis of observational data from registries as well as from randomized controlled trials has failed to show a significant increase in the risk of ly…